Skip to main content

Articles

Perspectives
A New Beginning
Read More
Practice Management
Trends in Biologic Therapies for Rheumatoid Arthritis: Results from a Survey of Payers and Providers
Stakeholder Perspective
Biologic Therapies for Rheumatoid Arthritis: It's All about Value
Read More
Practice Management
Impact of the Removal of the Monthly Liver Function Test Requirement for Ambrisentan
Stakeholder Perspective
The Challenges of Pulmonary Arterial Hypertension Management: Potential Benefits of Removing Monthly Testing
Read More
First Cost Analysis of Long-Term Management of CML
Read More
Practice Management
Beyond the Cost of Biologics: Employer Survey Reveals Gap in Understanding Role of Specialty Pharmacy and Benefit Design
Stakeholder Perspective
An Educated Consumer Is Our Best Customer
Read More
Practice Management
Employers, Health Plans, and New Drug Benefit Designs: A Shifting Landscape
Read More
Graft-versus-Host Disease Often Leads to Posttransplant Readmission, High Costs
Read More
Is Plerixafor Cost-Effective for Stem-Cell Mobilization?
Read More
Leukemia, Oncology
Bosutinib Shows Superior Results in CML
Read More
Leukemia, Oncology
Novel Oral B-Cell Receptor Inhibitor Very Effective in Chronic Lymphocytic Leukemia
Read More
Page 206 of 244
Results 2051 - 2060 of 2434